Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.61 | 9.18 |
| PEG Ratio (TTM) | 0.25 | 3.38 |
| P/S Ratio (TTM) | 1.72 | 1.50 |
| P/B Ratio (TTM) | 2.60 | 3.53 |
| P/FCF Ratio (TTM) | 3.26 | 7.08 |
| Price to 5YR AVG Earnings Ratio | 50.83 | 17.69 |
| Price to 5YR AVG FCF Ratio | 14.10 | 11.50 |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.30% | 3.93% |
| ROE (TTM) | 44.73% | 15.64% |
| Net Profit Margin (TTM) | 21.63% | 8.99% |
| ROIC 5YR AVG | -1,999.96% | 7.97% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 51.62% | -6.82% | -113.69% |
| Revenue | 13.45% | 22.23% | 19.87% |
| Net Income | 58.46% | -6.68% | -125.85% |
| Cash Flow | 48.87% | 52.29% | 389,683.04% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.59 | 1.27 |
| Quick Ratio (TTM) | 6.13 | 3.39 |
| D/E Ratio (TTM) | 0.41 | 0.30 |
| Interest Coverage (TTM) | 30.23 | 17.66 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 2.39 | 1.79 |
| LTL to 5YR AVG FCF | 2.42 | 1.46 |
| Shares Outstanding Growth 5YR AVG | 1.39% | -1.48% |